Stanford Team Proposes Automated Clinical Trial Accrual Strategy, Increased Trial Annotation – Precision Oncology News

NEW YORK Nam Bui has a piece of advice he wished he could share with more cancer patients: try to find a clinical trial.

Still, the Stanford University hematologist, academic oncologist, and medical oncology researcher recognizes the many obstacles to enrollment from geography to time-consuming trial criteria assessments. Not only is it difficult for clinicians to keep tabs on all of the trials open at a center at any given time, he argued, but the process of matching a patient to a trial can be time consuming.

Premium Access gives you: Full site access Interest-based email alerts Access to archives Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?Login Now.

*Before your trial expires, well put together a custom quote with your long-term premium options.

Continued here:

Stanford Team Proposes Automated Clinical Trial Accrual Strategy, Increased Trial Annotation - Precision Oncology News

Related Posts

Comments are closed.